Advertisement
Advertisement
Advertisement
Advertisement
China approved its first Covid-19 mRNA immunization

China approved its first Covid-19 mRNA immunization

China approved its first Covid-19 mRNA immunization

China approved its first Covid-19 mRNA immunization

Advertisement
  • Months after the relaxation of strict Covid-zero regulations caused an increase in cases.
  • China has authorized its first locally developed messenger RNA (mRNA) vaccine against Covid-19.
  • Beijing has rejected approval for the use of mRNA-based vaccines produced by the foreign companies Pfizer-BioNTech and Moderna.
Advertisement

Months after the relaxation of strict Covid-zero regulations caused an increase in cases, China has authorized its first locally developed messenger RNA (mRNA) vaccine against Covid-19, the vaccine’s manufacturer announced on Wednesday.

The vaccine was created by CSPC Pharmaceutical Group Ltd. and has been given “emergency use” approval by Beijing’s health authority, according to a statement from the firm.

The company added, without providing more information, that it demonstrated high efficacy in a trial where it was used as a booster shot for individuals who had already received other kinds of vaccines.

mRNA vaccines are regarded as some of the best at preventing fatal diseases and serious illnesses.

mRNA uses small pieces of genetic material that carry instructions telling the body’s cells how to produce a protein, in this case, the spike protein on the coronavirus that causes Covid, whereas conventional vaccines use weakened or inactivated germs to prepare the body for a future attack from the real virus.

The defense system of the body then releases antibodies to combat that spike protein, preparing it for the arrival of the actual coronavirus.

Advertisement

Beijing has rejected approval for the use of mRNA-based vaccines produced by the foreign companies Pfizer-BioNTech and Moderna.

Its lack of vaccination was generally believed to have contributed to more serious infections and fatalities after lockdowns and requirements for mandatory quarantine were abruptly lifted in December.

CanSino and other Chinese pharmaceutical companies have previously stated they are working on mRNA-based vaccines to close the country’s immunization deficit.

Also Read

171 new covid-19 cases reported, positivity jumps to 2.70%
171 new covid-19 cases reported, positivity jumps to 2.70%

Covid-19 cases once again on a rise in Pakistan 171 new covid-19...

Advertisement
Advertisement
Read More News On

Catch all the World News, Breaking News Event and Latest News Updates on The BOL News


Download The BOL News App to get the Daily News Update & Follow us on Google News.


End of Article

Next Story